Last reviewed · How we verify
Sepia 30C
Sepia 30C is a homeopathic remedy derived from cuttlefish ink, used in traditional homeopathic medicine based on the principle of treating symptoms with highly diluted substances.
Sepia 30C is a homeopathic remedy derived from cuttlefish ink, used in traditional homeopathic medicine based on the principle of treating symptoms with highly diluted substances. Used for Various symptoms traditionally treated in homeopathic practice (no FDA-approved indications).
At a glance
| Generic name | Sepia 30C |
|---|---|
| Also known as | Active Sepia |
| Sponsor | Shaare Zedek Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Sepia 30C is prepared through serial dilution and succussion (vigorous shaking) of cuttlefish ink according to homeopathic protocols. The '30C' designation indicates a 30-fold centesimal dilution, meaning the original substance has been diluted beyond the point where molecular traces typically remain. In homeopathic practice, it is claimed to address various symptoms, though no conventional pharmacological mechanism has been established.
Approved indications
- Various symptoms traditionally treated in homeopathic practice (no FDA-approved indications)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sepia 30C CI brief — competitive landscape report
- Sepia 30C updates RSS · CI watch RSS
- Shaare Zedek Medical Center portfolio CI